Pain Patch Market Report 2025

The pain patch market size has grown strongly in recent years. It will grow from $4.24 billion in 2024 to $4.48 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increased acceptance of non-invasive pain management techniques, prevalence of road accidents, increased chronic illness, increased post-surgery pain, increased prevalence of trauma and injuries.

The pain patch market size is expected to see strong growth in the next few years. It will grow to $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing adoption of opioids for pain management, increasing demand for targeted pain relief with minimal systemic side effects, changes in lifestyle, emergence of more office-related jobs, increasing need for convenient and easy-to-use effective option. Major trends in the forecast period include innovative solutions, incorporating advanced drug delivery technologies, key players' partnerships, technological advancements, strategic collaborations.

The rising prevalence of pain disorders is expected to significantly boost the growth of the pain patch market. Pain disorders encompass various conditions where pain is the primary symptom, often caused by psychological stress, inflammatory diseases, or physical trauma. Pain patches offer a targeted solution by delivering medication directly through the skin into the bloodstream, providing controlled and sustained relief over an extended period. For example, a December 2023 report from the Scottish Health Survey revealed that in 2022, over one-third (38%) of adults in Scotland experienced pain or discomfort lasting three months or more, with women reporting higher rates (43%) than men (33%). This increasing incidence of chronic pain highlights the growing demand for effective pain management solutions, positioning pain patches as a valuable option for consumers seeking relief. Therefore, the rise in pain disorders will continue to drive the growth of the pain patch market.

The anticipated growth of the pain patch market is also expected to be driven by the increasing healthcare expenditure. Healthcare expenditure, representing the total spending on healthcare goods and services within a specific timeframe, provides valuable insights into the economic impact and feasibility of implementing pain patches in healthcare systems. For instance, according to the Canadian Institute for Health Information in November 2022, healthcare expenditure rose to 0.8%, totaling $331 billion in 2022, compared to 7.6% in 2021. Therefore, the upward trajectory of healthcare expenditure is a key factor driving the growth of the pain patch market.

A noteworthy trend gaining popularity in the pain patch market is the advancement of innovative technologies. Major companies in the market are focusing on the development of cutting-edge technologies to enhance their market position. For instance, in June 2022, Hisamitsu Pharmaceutical Co. Inc., a Japan-based pharmaceutical company, introduced the Salonpas Pain Relieving Flex Patch. This innovative pain relief patch, containing 4% lidocaine, employs a thin, flexible, and highly adhesive patch technology. The advanced patch fabric, infused with lidocaine, maximizes the prescription's effectiveness for immediate pain relief, showcasing the industry's commitment to innovation.

Major companies operating in the pain patch market are also investing in the development of reusable pain patch products to enhance profitability. Reusable pain patch products are designed for multiple uses without compromising their efficacy in pain management. In November 2023, Signal Relief, a US-based pain management solutions provider, launched the Signal Relief Pain Patch. This drug-free and non-invasive pain relief patch utilizes microscopic particles as pain signal antennas to reroute and interrupt pain messages, providing long-lasting relief. The reusable nature of the patch, coupled with its wireless and chemical-free design, offers an innovative approach to pain management.

In July 2024, Grünenthal, a Germany-based pharmaceutical company, announced the acquisition of Valinor Pharma for $250 million. This strategic move is intended to enhance Grünenthal's portfolio in pain management and bolster its capabilities in creating innovative therapies for patients with unmet medical needs. Valinor Pharma, a Canada-based biotechnology company, specializes in developing therapies for rare diseases and complex medical conditions, aligning well with Grünenthal's focus on advancing treatment options in the pain management sector. This acquisition reflects Grünenthal's commitment to expanding its impact in the pharmaceutical market, particularly in addressing challenging medical issues.

Major companies operating in the pain patch market include CVS Health Corporation, Walgreens Boots Alliance Inc., Pfizer Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Rite Aid Corporation, Reckitt Benckiser Group plc, Viatris Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Hikma Pharmaceuticals plc, Endo International plc, Amneal Pharmaceuticals LLC, Grünenthal Group, Allergan plc, Hisamitsu Pharmaceutical Co. Inc., NICHIBAN Co. Ltd., Teikoku Seiyaku Co. Ltd., Haw Par Corporation, Sorrento Therapeutics Inc., Nanjing Joyful Industrial Co. Ltd., NEXGEL Inc.

North America was the largest region in the pain patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pain patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pain patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

A pain patch is a transdermal medication designed for the management of acute and chronic pain. It is utilized to alleviate severe pain, such as chronic pain or post-surgical pain, by delivering consistent doses of medication into the bloodstream through the skin.

The primary types of pain patches include opioid and non-opioid patches. Opioids are a class of drugs used to alleviate moderate to severe pain. Opioid patches are employed in pain management to address severe pain with minimal side effects. These patches are administered through metered-dose and microneedle patches, serving purposes such as pain relief, anesthesia, smoking cessation, cough suppression, and diarrhea suppression. Distribution of these patches occurs through various channels, including online pharmacies, retail pharmacies, and hospital pharmacies.

The pain patch research report is one of a series of new reports that provides pain patch market statistics, including the pain patch industry's global market size, regional shares, competitors with pain patch market share, detailed pain patch market segments, market trends and opportunities, and any further data you may need to thrive in the pain patch industry. This pain patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pain patch market consists of sales of fentanyl patches, clonidine patches, nitroglycerin patches, buprenorphine, diclofenac patches, lidocaine patches, ketoprofen patches, capsaicin patches, and methyl salicylate patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.